
Roche chairman standing down
pharmafile | March 13, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Roche, humer
The chairman of the Board of directors at Roche, Franz Humer, has announced that he will not stand for re-election to the Board in 2014.
The firm will nominate a successor for the chairmanship in autumn 2013. Roche has decided that Humer’s successor will also serve as non-executive chairman, thus maintaining the established separation of the offices of chairman and chief executive.
Humer said: “Roche is in excellent shape and well positioned to meet future challenges. This is a good time to hand over to a successor. I am looking forward to the next 12 months, and I intend to perform my duties as chairman with enthusiasm and drive.”
Related Content

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory
Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance …

Roche receives CE Mark for blood test to help rule out Alzheimer’s
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

Roche candidate shows early promise for treating haemophilia A
Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational …






